Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 8, 2009, Pages 478-482

  Shaikh, Samiullah ^a   Memon, Muhammad Sadik ^b   Ghani, Hanif ^a   Baloch, Ghulam Hussain ^a   Jaffery, Mukhtiar ^a   Shaikh, Khalid ^a  

^a LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES   (Pakistan)

^b ISRA UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Alanine aminotransferase; Aspartate aminotransferase; Biomarkers; Hepatitis C; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; VIRUS RNA;

ADULT; ARTICLE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; THROMBOCYTE COUNT;

EID: 71949092498     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3:41-46
2. McHutchison JG, Gordon SC, Schiff ER, Shiftman ML, Lee WM, Rustqi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:1485-1492
3. Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, et al. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002; 36:S161-72.
4. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002. Hepatology 2002; 36:S3-20.
5. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management and treatment of hepatitis C. Hepatology 2004; 39: 1147-1171
6. Regev A, Berho M, Jeffers LJ, Minkowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intra-observer variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97:2614-2618
7. Sebastiani G, Alberti A. Non-invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12:3682-3694 (Pubitemid 43950946)
8. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007; 46:912-921 (Pubitemid 47436137)
9. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple non-invasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43:1317-1325 (Pubitemid 43980111)
10. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-526
11. Vallet-Pichard A, Mallet V, Nalpas B, Verkarra V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007; 46:32-36
12. Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O, Yano M. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology 1997; 25:1028-1031 (Pubitemid 27157152)
13. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24:289-293 (Pubitemid 26260021)
14. Cross T, Antoniades C, Harrison P. Non-invasive markers for the prediction of fibrosis in chronic hepatitis C infection. Hepatol Res 2008; 38:762-769 (Pubitemid 352015625)
15. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-843
16. Anderson FH, Zeng L, Rock NR, Yoshida EM. An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C. Hepatol Res 2000; 18:63-71. (Pubitemid 30330696)
17. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, et al. Non-invasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113:1609-1616 (Pubitemid 27461247)
18. Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, et.al. Non-invasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection. Liver International 2006; 26:1095-1099
19. Park GJ, Lin BP, Ngu MC, Jones DB, Katelaris PH. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol 2000; 15:386-390
20. Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003; 163:218-224 (Pubitemid 36120190)
21. Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005; 41: 1376-1382 (Pubitemid 40770291)